Skip Navigation

Search Archive

Show Advanced Search

Features archive results 1-9 of 9 in Health and Access to medicine

Therapeutic vaccines: a new hope for chronic diseases?

Vaccines for non-infectious illness could help developing nations tackle the growing burden of chronic disease. Maryke Steffens reports.

FEATURE | 23 July 2008 | EN | ES | FR | 中文

Q&A: Advocating open source drugs

Leading geneticist Samir Brahmachari explains why India should kickstart a new open source approach to drug discovery for diseases like TB.

FEATURE | 12 June 2008 | EN | 中文

Antibiotic resistance and the developing world

Many factors are increasing antibiotic resistance, and authorities, doctors and patients all have a role in fighting it, writes Jia Hepeng.

FEATURE | 26 March 2008 | EN | ES | FR | 中文

Agreeing to disagree: Andean trade deals with the US

As three Andean nations forge ahead with free trade agreements with the United States, Lisbeth Fog reports on the implications for healthcare, research and regional stability.

FEATURE | 28 April 2006 | EN | ES

Making Tamiflu cheap enough for the poor

As production of flu drug Tamiflu gears up, big questions remain over how affordable — and effective — it will be, reports Martin Enserink.

FEATURE | 21 April 2006 | EN

Africa, Middle East, Latin America prepare for bird flu

SciDev.Net journalists report on efforts to face bird flu in Africa, the Middle East and Latin America.

FEATURE | 27 October 2005 | EN

India's biotech sector: boom or bust

India's biotechnology sector is thriving, but K. S. Jayaraman asks whether simply increasing investment will be enough to sustain it.

FEATURE | 5 August 2005 | EN

China's scientific shortcut to new drugs

Jia Hepeng describes how Chinese researchers are changing the way they use herbal remedies to compete on the international pharmaceutical market.

FEATURE | 4 July 2005 | EN | 中文

Developing world is approaching R&D needs creatively

Poorer countries are pioneering creative approaches to health research, from developing new drugs to taking an innovative part in the global pharmaceuticals business, reports Fiona Fleck.

FEATURE | 17 January 2005 | EN